FSM Wealth Advisors LLC Acquires New Holdings in Zoetis Inc. (NYSE:ZTS)

FSM Wealth Advisors LLC acquired a new stake in Zoetis Inc. (NYSE:ZTS) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,243 shares of the company’s stock, valued at approximately $243,000.

Other large investors have also recently added to or reduced their stakes in the company. Quarry LP lifted its holdings in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after purchasing an additional 153 shares in the last quarter. LRI Investments LLC purchased a new position in Zoetis in the 1st quarter valued at about $43,000. Fortitude Family Office LLC lifted its holdings in Zoetis by 1,387.5% in the 3rd quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after purchasing an additional 222 shares in the last quarter. Central Valley Advisors LLC purchased a new position in Zoetis in the 2nd quarter valued at about $49,000. Finally, EdgeRock Capital LLC purchased a new position in Zoetis in the 2nd quarter valued at about $56,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Stock Up 0.1 %

ZTS opened at $175.27 on Wednesday. The firm has a 50 day moving average price of $188.71 and a 200 day moving average price of $179.23. The company has a market cap of $79.41 billion, a PE ratio of 32.95, a price-to-earnings-growth ratio of 2.68 and a beta of 0.90. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45.

Zoetis (NYSE:ZTS) last posted its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 52.59%. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter in the prior year, the company earned $1.36 EPS. The company’s revenue was up 11.6% on a year-over-year basis. Sell-side analysts expect that Zoetis Inc. will post 5.91 earnings per share for the current year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be given a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is 32.52%.

Analyst Upgrades and Downgrades

ZTS has been the topic of a number of recent research reports. Piper Sandler upped their target price on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. JPMorgan Chase & Co. increased their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Stifel Nicolaus increased their price objective on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. BTIG Research increased their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Finally, Argus upgraded shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Ten analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $221.44.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.